Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04895995 · ClinicalTrials.gov registry record · NA

Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population

A NA study of Anxiety and Cardiovascular Diseases, sponsored by Boston University Charles River Campus.

Recruiting
Registry status
NA
Development phase
95
Enrollment target
1
Study location

NCT04895995: Recruiting NA study of Anxiety and Cardiovascular Diseases, sponsored by Boston University Charles River Campus.

NCT04895995 is a NA study of Anxiety and Cardiovascular Diseases that is actively recruiting participants, run by Boston University Charles River Campus. The registered enrollment target is 95 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04895995, a NA study of Anxiety and Cardiovascular Diseases, is actively recruiting participants, sponsored by Boston University Charles River Campus.

RECRUITING
Registry status
NA
Development phase
95 participants
Enrollment target
1
Study location

Study Summary

The treatment of generalized anxiety disorder (GAD) in an accessible manner represents an unmet need for those with cardiovascular disease (CVD), given that patients with CVD experience numerous barriers for in-person treatment engagement. The research plan for the proposed pilot project will entail: (1) open study of the acceptability of the digital intervention (N=5), followed by (2) recruitment and randomization of 90 individuals with a history of acute CVD events and clinical levels of GAD symptoms to dCBT or a waitlist (Control) condition, using a 1.5:1 allocation (dCBT:Control).

Primary Outcome

Well validated self-report measure of generalized anxiety disorder symptoms. Scores can range from 0 to 21 with higher scores indicating greater anxiety.

Interventions

  • BEHAVIORAL Daylight dCBT Application

Study Locations (1)

Massachusetts

  • Boston University - Boston

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2022-02-02
Est. Completion 2026-03-15
Phase NA

What NCT04895995 shows while recruiting

NCT04895995 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (78% lower).

The record links to 4 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Daylight dCBT Application is the first listed.

NCT04895995 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04895995 about?

NCT04895995 is a clinical study titled "Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population". The treatment of generalized anxiety disorder (GAD) in an accessible manner represents an unmet need for those with cardiovascular disease (CVD), given that patients with CVD experience numerous barriers for in-person treatment engagement. The research plan for the proposed pilot project will entail...

What is the current status of trial NCT04895995?

This trial is currently recruiting. It is a NA study. The enrollment target is 95 participants. The study started on 2022-02-02. Estimated completion is 2026-03-15.

What conditions does trial NCT04895995 study?

This clinical trial studies the following conditions: Anxiety, Cardiovascular Diseases, Anxiety Disorders, Health Behavior.

What interventions are being tested in trial NCT04895995?

The interventions under investigation include: Daylight dCBT Application (BEHAVIORAL).

Who is sponsoring clinical trial NCT04895995?

This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04895995 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04895995's enrollment target sits among peer trials

95 181st of 364 higher than 182 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03339128 · 95 participants · Phase 2

    Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

  • NCT03509961 · 95 participants · Phase 2

    The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

  • NCT03694756 · 95 participants · NA

    TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer

  • NCT04206215 · 95 participants · NA

    Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04895995, the US trial registry maintained by the National Library of Medicine. NCT04895995 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.